DOSSIER · 13F Holders · Q3 2026

LIGAND PHARMACEUTICALS INC CON

1 institutions still hold LIGAND PHARMACEUTICALS INC CON as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 532CNT011·1 13F holders·last filed Sep 30, 2026
Market cap
—
13F value held
—
visible holders
Holders
1
filers reporting
Concentration
—
Sterling Capital Management LLC #1
top holder share
AI Holders Summary · Q3 2026

1 institutions reported LIGAND PHARMACEUTICALS INC CON in Q3 2026. Top-holder concentration data is loading.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Sterling Capital Management LLC
CIK 0001329883
$0230.00%Q3 2026